Stay updated on SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.6.6 has been introduced, replacing the previous v3.6.5. This change indicates a minor version update with no visible changes to the page content or user experience.
    Difference
    0.0%
    Check dated 2026-09-01T18:11:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new line was added under Other Study ID Numbers: 2018(U.S. NIH Grant/Contract), indicating a funding source for the study.
    Difference
    0.0%
    Check dated 2026-08-25T16:41:15.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows a Revision: v3.6.5, updating the previous v3.6.4 label. This reflects a routine software revision with no changes to the study details or user-facing features.
    Difference
    0.0%
    Check dated 2026-08-11T08:13:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a minor version deployment. The update does not indicate changes to study content or public-facing information on this view.
    Difference
    0.0%
    Check dated 2026-07-28T05:27:23.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a minor version update to the page. No visible content or user-facing changes are indicated by the data provided.
    Difference
    0.0%
    Check dated 2026-07-06T16:46:08.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page revision label was changed from v3.6.0 to v3.6.2, signaling a minor update to the page. This update does not modify study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-29T10:59:56.000Z thumbnail image

Stay in the know with updates to SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.